Connect with us

Technology

ChemAI: AI-Driven Digital Chemistry Pioneer announces Strategic Rebrand and Key Board Appointments

Published

on

LEEDS, England, Nov. 27, 2024 /PRNewswire/ — Deepmatter, a leading innovator in digital chemistry, today unveils its rebrand to ChemAI, as part of a strategic growth plan to revolutionize the future of chemistry with artificial intelligence (AI). The rebrand reflects the company’s vision to empower scientists with advanced AI tools that redefine chemical discovery and manufacturing.

Over recent years, ChemAI has developed and commercialised a suite of AI-driven tools that enable chemists to dramatically improve the efficiency and cost-effectiveness of synthetic routes and formulations. These tools also uncover novel and innovative synthetic pathways. The AI is underpinned by access to proprietary data: a comprehensive and growing chemical database of over 23 million chemical reactions.

Already collaborating with leading pharmaceutical, biotech, and cosmetic firms, ChemAI’s rebranding underscores its mission to harness AI and data-driven innovation to transform the discovery, development, and production of chemical products.

In conjunction with its rebrand, ChemAI announces significant additions to its Board of Directors to support the company’s next growth phase:

Dave Norwood has been appointed Chairman. A seasoned leader in deep-tech and life sciences, Dave is the founder of IP Group PLC and Oxford Science Enterprises, which has driven over £1.5 billion in investments into Oxford since 2015. He also co-founded Oxford Nanopore, a global leader in DNA sequencing, among other notable UK tech companies.Tony de Fougerolles, PhD has joined as a Non-Executive Director, bringing over 25 years of experience in biotechnology R&D, most recently CEO of Evox Therapeutics. Tony previously served as CSO at Ablynx, where he contributed to the approval of caplacizumab, the first single-domain antibody drug, and advanced immunology and oncology pipelines. As founding CSO at Moderna, he pioneered the foundational mRNA science that underpins the entire sector including the approved mRNA vaccines. He also held leadership roles at Tolerx and Alnylam. Tony serves on the boards of Etherna, Chimeron Bio, Helfie AI and Lift Biosciences. He earned a PhD in Immunology from Harvard and a BSc from McGill.

Commenting on these developments, Dave Norwood, Chairman, said:

“The rebrand to ChemAI reflects our bold ambition to redefine the role of data and AI in chemistry. By combining a visionary approach with a strengthened leadership team, ChemAI is well-positioned to drive transformative change and unlock unprecedented opportunities in the chemical and pharmaceutical industries.”

Tony de Fougerolles, Non-Executive Director, added:

“I’m thrilled to join ChemAI at such an exciting juncture. The company’s AI-powered platform has immense potential to accelerate innovation and improve efficiencies across the chemical ecosystem. Our approach to AI won’t replace chemists entirely, but chemists using our tools will be immeasurably more productive and creative than those that don’t”

ChemAI’s rebrand and new Board appointments underscore its commitment to empowering researchers, manufacturers, and innovators with tools that enhance productivity, sustainability, and innovation. As ChemAI, the company remains steadfast in its mission to create a world where data and AI-driven chemistry fuel solutions for global challenges.

About ChemAI

ChemAI (formerly Deepmatter) is a UK-based privately-held technology company leading innovation in digital chemistry. Leveraging AI, machine learning, , ChemAI optimizes chemical research and manufacturing, driving breakthroughs across the chemical, pharmaceutical, and material science industries. Its proprietary platform combines proprietary chemical reaction data, large language model (LLM)-enabled data extraction tools, and domain-specific AI for route prediction, reaction optimization, and automation control.

For more information, visit chemai.io

Logo: https://mma.prnewswire.com/media/2568474/ChemAI_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/chemai-ai-driven-digital-chemistry-pioneer-announces-strategic-rebrand-and-key-board-appointments-302317406.html

SOURCE ChemAI Ltd

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ivalua Wins Prestigious Procurement Leaders Asia Pacific Solution Provider Award

Published

on

By

REDWOOD CITY, Calif., Nov. 27, 2024 /PRNewswire/ — Ivalua, a global leader in spend management, is proud to announce that it has won the Asia Pacific Solution Provider award at the Procurement Leaders Asia Pacific Procurement Awards 2024 ceremony in Singapore. This marks the third award in the past four months recognizing Ivalua as the top procurement solution provider.

This prestigious awards ceremony recognizes and celebrates organizations and individuals for their outstanding excellence and innovation within the procurement industry across the Asia-Pacific region. The Asia Pacific Solution Provider Award recognizes the solution provider that demonstrates the most impactful and valuable technology or service for procurement functions. It is the only award given to a technology provider.

In recent years, Ivalua has further intensified its investments in the Asia Pacific region to maximize the growing opportunities presented by this dynamic market. In particular, Ivalua has been supporting the procurement digitalization of several leading organizations including BAE Systems Australia, CIMB, SA Water, Air New Zealand, UNSW, Maxis, Jollibee, Dole Sunshine, Piramal Glass, Asian Paints, and more.

“We are honored to receive this prestigious award, which is a testament to the dedication of the entire Ivalua team and recognizes our commitment to supporting organizations in the Asia Pacific region with our market-leading solution. This win motivates us further to continue to drive excellence and innovation with our customers and partners in APAC,” said Andrew Stafford, VP, APAC, at Ivalua.

This award marks the third win in recent months for Ivalua following the Best Source-to-Pay (S2P) Technology Provider Award at the CPO Asia Summit & Awards held in Kuala Lumpur, Malaysia, and the Best Procurement Solution Provider accolade at the UAE 100 CPO Summit & Awards in Dubai.

About the Asia Pacific Procurement Awards

The Asia Pacific Procurement Awards honor organizations and individuals who have made significant contributions to procurement, setting new standards, and driving innovation and social impact within their organizations and communities. An independent panel of esteemed judges featuring procurement leaders from organisations such as Air New Zealand, Asian Development Bank, and EnergyAustralia, meticulously evaluated the entries. Their rigorous assessment selected only the most worthy winners from many inspiring entries.

About Ivalua

Ivalua is a leading provider of cloud-based, AI-powered Spend Management software. Our unified Source-to-Pay platform empowers businesses to effectively manage all categories of spend and all suppliers, increasing profitability, improving sustainability, lowering risk and boosting employee productivity. We are trusted by hundreds of the world’s most admired brands and recognized as a leader by Gartner and other analysts. Learn more at www.ivalua.com. Follow us on LinkedIn and X.

Global Media Contact

Corporate Communications

media@ivalua.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ivalua-wins-prestigious-procurement-leaders-asia-pacific-solution-provider-award-302316722.html

SOURCE Ivalua

Continue Reading

Technology

Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging

Published

on

By

AI-powered chest X-ray and mammography analysis solutions to be deployed across one of Mexico’s largest healthcare networks

SEOUL, South Korea, Nov. 27, 2024 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with Salud Digna, one of Mexico’s largest medical networks. Under the agreement, Lunit will deliver its AI-powered medical imaging solutions to Salud Digna’s extensive network of over 230 clinics across Mexico and Central America.

The deal centers on two of Lunit’s flagship products:

Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solutionLunit INSIGHT MMG, an AI software for mammography analysis

These cutting-edge tools are set to enhance diagnostic capabilities for Salud Digna, which treats approximately 20 million patients annually.

As part of the arrangement, Lunit will also gain access to Salud Digna’s substantial database, comprising millions of deidentified 2D mammography and chest X-ray images. This high-quality data will help Lunit refine its AI algorithms, particularly for the Latin American market.

“By integrating Lunit’s advanced AI into our healthcare network, we aim to improve the accuracy and efficiency of our imaging services,” said Juan Carlos Ordoñez, CEO of Salud Digna. “Together, we are committed to leveraging our extensive data resources to drive innovation in medical imaging and ultimately improve patient care across the region.”

The collaboration extends beyond a traditional supplier-client relationship. Lunit and Salud Digna will engage in joint research projects, leveraging the shared data to further advance medical imaging AI technology and showcase the impact of this partnership on healthcare delivery in Mexico and across the Latin American region. 

“This multifaceted partnership with Salud Digna marks a milestone in our global expansion and our mission to improve patient outcomes through AI,” said Brandon Suh, CEO of Lunit. “By combining our cutting-edge AI technology with Salud Digna’s vast clinical experience and extensive patient data, we’re not just supplying software – we’re collaborating to advance medical imaging AI technology tailored to the needs of patients in Mexico and potentially the broader Latin American region.”

About Lunit

Founded in 2013, Lunit (KRX:328130.KQ) is a medical AI company on a mission to conquer cancer. We harness AI-powered medical image analytics and AI biomarkers to ensure accurate diagnosis and optimal treatment for each cancer patient. Our FDA-cleared Lunit INSIGHT suite for cancer screening serves over 4,500 hospitals and medical institutions across 55+ countries.

Our clinical studies have been published in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast health and screening technologies. Headquartered in Seoul, South Korea, with a network of offices worldwide, Lunit leads the global fight against cancer. Discover more at lunit.io.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunit-inks-partnership-with-salud-digna-to-advance-ai-in-medical-imaging-302316214.html

SOURCE Lunit

Continue Reading

Technology

SOS Announces Plans to Strengthen Global Crypto Investment Strategy and Purchase up to $50 Million Worth of Bitcoin

Published

on

By

NEW YORK, Nov. 27, 2024 /PRNewswire/ — SOS Ltd., a multifaceted company that engages in the blockchain, cryptocurrency operations and commodity trading, today announced the Board of Directors approved its plan to invest $50 million to purchase Bitcoin (BTC). This initiative underscores SOS’s commitment to advancing its blockchain business and solidifies the Company’s long-term belief in Bitcoin‘s role as a store of value and a strategic asset.  

The purchase plan comes as Bitcoin reaches historic highs and continues to capture global investors’ interest. According to the latest market data, Bitcoin‘s price has soared to around $93,000 per coin, with projections suggesting it may surpass the $100,000 milestone by year-end. SOS’s investment strategy aligns closely with the positive momentum in the cryptocurrency market, including a more favorable U.S. policy environment toward digital assets and growing institutional support for Bitcoin.

To maximize returns and mitigate market volatility, SOS plans to employ a variety of quantitative trading strategies, including investing, trading and arbitrage strategies.

These strategies are designed to achieve steady returns in the market environment while optimizing the Company’s investment portfolio over time. 

This move highlights SOS Ltd. efforts to expand digital asset investments. SOS believes Bitcoin is not only a cornerstone of the digital asset ecosystem but also has the potential to become a key global strategic reserve asset. The company remains committed to delivering long-term value to its shareholders and investors through continued investment and technological innovation.

Yandai Wang, Chairman and CEO of SOS, commented, “Bitcoin market performance is robust and supported by positive developments such as the launch of several Bitcoin-related ETF options and ongoing improvements in the U.S. regulatory environment for digital assets. We believe this investment plan will further enhance the Company’s overall competitiveness and profitability in the digital asset investment sector.” 

About SOS Limited

SOS is a multifaceted company that engages in the blockchain, cryptocurrency operations and commodity trading. At present, it includes cryptocurrency mining and may be extended to cryptocurrency security and insurance in the future. Since April 2021, we have carried out commodity transactions through our subsidiary SOS International Trading Co., Ltd. (the core infrastructure of SOS marketing data). The technologies and solutions of insurance and emergency rescue services are based on big data, blockchain based technology, cloud computing, artificial intelligence, satellite and 5G network. SOS has created a cloud “software as a service (SaaS)” platform for emergency rescue services. The products are divided into three categories: basic cloud, cooperative cloud and information cloud. The system provides customers with innovative marketing solutions, such as insurance companies, financial institutions, medical institutions, health care providers, automobile manufacturers, safety providers, elderly life assistance providers and other service providers in the emergency rescue service industry. For more information, visit: http://www.sosyun.com/.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Federal Securities Act, including but not limited to our expectations of future financial performance, business strategy or business. These statements constitute forecasts, prospects and forward-looking statements and are not performance guarantees. SOS warns that forward-looking statements are subject to many assumptions, risks and uncertainties that will change over time. Forward looking statements may be identified by words such as “may”, “can”, “should”, “will”, “estimate”, “plan”, “project”, “forecast”, “intend”, “expect”, “predict”, “believe”, “seek”, “target”, “Outlook” or similar words. Specifically, forward-looking statements may include statements related to the following matters of the company:

Ability to implement its business plan;

Changes in SOS product and service market; and

Expansion plans and opportunities.

These forward-looking statements are based on information available as of the date of this press release and our management’s current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

These risks and uncertainties include, but not are limited to, the risk factors described by SOS in its filings with the Securities and Exchange Commission (“SEC”). These risk factors and those identified elsewhere in this press release, among others, could cause actual results to differ materially from historical performance and include, but are not limited to:

Local government’s policies and regulatory oversight of crypto currency mining operation and our other operations;SOS’s blockchain and super-computing, commodity trading and marketing solutions businesses are still under development, with many uncertainties in the future direction and integration of these various business segments;Failure to manage the newly launched commodities trading business effectively;Loss of key customers in the commodity trading business;Failure to access a large quantity of power at reasonable costs could significantly increase SOS operating expenses and adversely affect our demand for SOS’s mining activities;Any significant or prolonged failure in the data warehouse facilities and data mining facilities that SOS operates or services it provides, including events beyond its control, would lead to significant costs and disruptions and would reduce the attractiveness of its facilities, harm its business reputation and have a material adverse effect on its results of operation;Security breaches or alleged security breaches of our data warehouses could disrupt SOS operations and have a material adverse effect on its business, financial condition and results of operation; uncertainty in global supply chain and international shipping; andOther risks and uncertainties indicated in SOS’s SEC reports or documents filed or to be filed with the SEC by SOS.

Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and you should not place undue reliance on these forward-looking statements in deciding whether to invest in our securities. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

View original content:https://www.prnewswire.com/news-releases/sos-announces-plans-to-strengthen-global-crypto-investment-strategy-and-purchase-up-to-50-million-worth-of-bitcoin-302317469.html

SOURCE SOS Ltd.

Continue Reading

Trending